Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,730
Stocks News & Analysis
stocks
What next for the largest company on the ASX?
stocks
Ask the analyst: Are IDP Education's woes temporary?
stocks
Is it time to buy the Magnificent Seven?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,013.30 | 46.70 | 0.59% |
CAC 40 | 8,028.28 | 90.07 | 1.13% |
DAX 40 | 22,986.82 | 419.68 | 1.86% |
Dow JONES (US) | 41,488.19 | 674.62 | 1.65% |
FTSE 100 | 8,632.33 | 89.77 | 1.05% |
HKSE | 23,959.98 | 497.33 | 2.12% |
NASDAQ | 17,754.09 | 451.07 | 2.61% |
Nikkei 225 | 37,053.10 | 263.07 | 0.72% |
NZX 50 Index | 12,266.25 | 57.20 | 0.47% |
S&P 500 | 5,638.94 | 117.42 | 2.13% |
S&P/ASX 200 | 7,789.70 | 40.60 | 0.52% |
SSE Composite Index | 3,419.56 | 60.83 | 1.81% |